Praj Hipurity Systems: Advancing Bespoke Pharma Turnkey Solutions With Leading-Edge Precision And Sustainable Excellence

Mihir Mehta, Executive V.P & Director

Mihir Mehta

Executive V.P & Director

The pharmaceutical turnkey project market is undergoing a significant transformation, driven by rapid technological advancements, heightened regulatory scrutiny, and the increasing demand for integrated, end-toend solutions. Automation and Industry 4.0 are reshaping production landscapes, enabling greater operational efficiency, adaptability, and real-time compliance management. At the same time, the growing emphasis on sustainable manufacturing and personalized medicine is pushing pharma companies to invest in flexible and intelligent systems. Turnkey solutions that deliver a streamlined approach from concept to commissioning have emerged as a vital enabler for organizations looking to meet evolving global standards while addressing complex therapeutic needs.

In this dynamic environment, Praj Hipurity Systems has established itself as a leading provider of turnkey solutions tailored for the pharmaceutical, biopharmaceutical, and life sciences sectors. Backed by decades of domain expertise, the firm delivers value across the project spectrum from design and engineering to execution and lifecycle support. By addressing key challenges such as stringent international compliance and intricate manufacturing demands, the firm offers clients a seamless and reliable path to operational excellence.

What truly differentiates Praj Hipurity Systems is its unmatched integration of advanced technologies and deeprooted focus on quality. The firm harnesses critical sterile ops centric process systems, and next-generation water solutions to ensure compliance without compromising on efficiency. Its robust compliance framework adheres strictly to global regulatory standards, while modular, scalable engineering minimizes downtime and enhances execution speed. Our holistic, innovation & problem solving led approach positions us as a trusted partner for pharma companies seeking efficiency, regulatory confidence, and future-ready infrastructure”, adds Mihir Mehta, Executive Vice President & Director, Praj Hipurity Systems.

Digitalization and Sustainability

With the pharmaceutical industry placing increasing emphasis on data integrity, traceability, and automation, Praj Hipurity Systems is at the forefront of integrating Industry 4.0 technologies into its turnkey project solutions. The firm employs advanced automation solutions which focus on lifecycle management, IoT-enabled systems and real-time monitoring tools to ensure seamless process integration and high-level data accuracy. These digital enablers not only enhance regulatory compliance but also support predictive maintenance and data-driven decision-making, helping clients achieve higher operational efficiency and reliability.

Sustainability has emerged as a key priority in pharmaceutical manufacturing, and Praj HiPurity has embedded eco-conscious practices into its engineering and project execution. The firm promotes the use of energy-efficient systems, water recycling mechanisms, and technologies that reduce environmental impact. A signature innovation is its Glacier Blue (Ambient Water for Injection- WFI system), designed to reduce energy consumption while maintaining uncompromised quality significantly. These sustainable initiatives reflect the firm’s commitment to balancing performance with environmental responsibility.

Its ability to deliver compliant, efficient, and future-ready solutions makes it a trusted partner to leading pharma and life sciences organizations worldwide

Mihir Mehta, Executive V.P & Director

Equally important is Praj Hipurity Systems’ ability to deliver highly customized turnkey solutions. Understanding that each pharmaceutical client operates under distinct regulatory frameworks, production volumes, and technical specifications, the firm adopts a consultative approach from project conception to execution. Its modular and scalable system designs allow for tailored configurations that align with specific product types, manufacturing requirements, and future expansion goals. Close collaboration with clients ensures that solutions are not only technically robust but also adaptable to evolving market demands.

By combining advanced digital technologies, sustainable engineering practices, and deep customization, Praj Hipurity Systems continues to set new benchmarks in the pharmaceutical turnkey project space. Its ability to deliver compliant, efficient, and future-ready solutions makes it a trusted partner to leading pharma and life sciences organizations worldwide.

Turnkey Solutions for a Smarter & Greener Pharma Industry

Praj Hipurity Systems has established itself as a trusted partner for some of the world’s leading pharmaceutical companies, particularly in the complex field of biopharma manufacturing. From biotech APIs to vaccines and monoclonal antibodies, the firm brings deep technical expertise and a strong commitment to meeting the highest global regulatory standards.

A major strength lies in its innovative water systems, including Ambient Water for Injection (WFI) solutions that combine sustainability with strict pharmacopeial compliance. These solutions are part of a broader turnkey offering that spans everything from clean utilities to sterile manufacturing and utility integration, all delivered as one seamless project.

What makes Praj Hipurity Systems stand out is its focus on the full project lifecycle. Clients benefit from continuous support from initial design and engineering to execution and long-term maintenance. The firm also integrates energyefficient technologies, water conservation, and eco-friendly materials to help clients meet their sustainability goals.

With operations across multiple countries, Praj Hipurity Systems is well-positioned to meet diverse regulatory needs. Its systems are also future-ready, designed to support emerging segments like cell and gene therapies, peptides, complex injectables & smart protein. To shape the future of pharmaceutical & nutraceuticals manufacturing with confidence and care, the firm keeps updated knowledge sharing and improved digital innovations.

Innovating for the Future

Praj Hipurity Systems is at the forefront of pharmaceutical innovation, actively developing advanced modular and scalable manufacturing platforms, continuous bioprocessing technologies, fermentation centric and sterile solutions. To its credit it operates & delivers real-time monitoring of fabricated systems with quality, reporting & timeline through its FIRST IN THE INDUSTRY EQMS (Electronic Quality Management System) indigenously developed for solving critical client concerns wrt time, quality & unfiltered reporting.

With the rise of cell and gene therapy, smart proteins, peptides & ever growing focus on injectables & biologics, Praj Hipurity Systems is tailoring its turnkey solutions to meet the specialized requirements of these emerging segments. The firm is engineering compact, high-precision modular systems designed for small-batch production with advanced process control and enhanced sterility, ensuring optimal compliance with global standards.

Looking ahead, Praj Hipurity Systems’ strategic growth plans include expanding its international presence through strengthened partnerships, focused investments in R&D, and continuous enhancement of its technological capabilities. The firm’s mission is clear, which is to empower pharmaceutical and biotech clients with sustainable, forward-thinking turnkey solutions.

“Beyond our technical capabilities, we are deeply committed to innovation, sustainability, and customer success. Its expertise spans solutions for sterile manufacturing, biopharma, biologics, nutraceuticals, smart proteins and critical water treatment, making it a trusted partner in delivering solutions that are as future-ready as they are reliable”, concludes Mihir Mehta.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.